External beam radiotherapy for patients presenting with hormone sensitive, low volume metastatic prostate cancer at the time of diagnosis

Document first published:: 4 November 2020
Page updated:: 5 October 2021
Topic:: Specialised commissioning
Publication type:: Policy or strategy

External beam radiotherapy to the prostate is recommended to be available as a treatment option through routine commissioning for patients presenting with hormone-sensitive, low volume metastatic prostate cancer at the time of diagnosis within the criteria set out in this document.